Charge-reversible and biodegradable chitosan-based microgels for lysozyme-triggered release of vancomycin

INTRODUCTION: High-dose drug administration for the conventional treatment of inflammatory bowel disease induces cumulative toxicity and serious side effects. Currently, few reports have introduced smart carriers for intestinal inflammation targeting toward the treatment of inflammatory bowel diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Hetjens, Laura, Wolter, Nadja, Li, Helin, Shi, Xiangyang, Pich, Andrij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811367/
https://www.ncbi.nlm.nih.gov/pubmed/36585117
http://dx.doi.org/10.1016/j.jare.2022.02.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811367/
https://www.ncbi.nlm.nih.gov/pubmed/36585117
http://dx.doi.org/10.1016/j.jare.2022.02.014

Ejemplares similares